Research & Education

CEO Statement - IASLC Applauds US Pharmacy’s Decision to Stop Selling Tobacco Products

Aurora, CO – CVS Caremark, a US-based pharmacy chain, announced Wednesday it will stop selling cigarettes and other tobacco products at its CVS/pharmacy stores by October 1.

Study Shows that Gene Signature Identifies High-Risk Patients with Early-Stage NSCLC

DENVER – Researchers have shown that testing for a specific collection of genes in early-stage non-small-cell lung cancer (NSCLC) tissue accurately predicts prognosis.

Early Study Suggests Sputum-Based Biomarkers May Add to Benefit of Screening

Testing May Improve Diagnosis of Lung Cancer in Smokers

DENVER – Researchers have found that analysis of microRNAs (miRNAs) in sputum increases the specificity of lung cancer screening with low-dose spiral computed tomography (LDCT).

Early Study Shows that Two Targeted Drugs with Chemotherapy Is Safe and Effective in Advanced NSCLC

Cetuximab and Bevacizumab Added to Chemotherapy

DENVER – A phase II study is the first to show that adding two targeted therapy drugs to the standard chemotherapy regimen is safe and effective as first-line treatment of advanced non-small-cell lung cancer (NSCLC)...

Clinicians Rate Patients with Lung Cancer with Poorer Quality of Life

Comparison with Patients with Other Types of Cancer

DENVER – Advances have been made in the treatment of lung cancer, but the disease continues to be a challenge to treat, primarily because of a high number of people who have late-stage cancer at the time of diagnosis, the likelihood of poor outcomes, and a greater symptom burden.

Soy may help protect lung cancer patients from side effects of radiation, initial study on mice

Latest in November issue of Journal of Thoracic Oncology

DENVER – Radiotherapy is a common treatment for patients with non–small-cell lung cancer. However, the side effects can include skin injury, hair loss, increased breathing rates, inflammation of the lung and fibrosis. Researchers from the Barbara Ann Karmanos Cancer Institute wanted to know if using soy isofavones would decrease toxicity.